BridgeMD
New treatment option for Infectious Disease
Official title A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
ClinicalTrials.gov ID: NCT06422338
What this study is testing
- What it's testing
- The overall aim of the study is to provide evidence that introducing novel biomarkers evaluation at triaging (first clinical assessment), in combination with IMCI-based guidelines (SoC), is a viable strategy to enhance rapid and accurate identification of febrile children at increased risk of life-threatening infections compared to IMCI-based strategies alone (SoC), and to demonstrate whether this results in enhanced decisions of admission/referral vs discharge, and enhanced overall health outcome of children with acute fever in sub-Saharan Africa.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 60
You may be able to join if
- Age ≥2 months and \<60 months
- Written informed consent from the child's parent or caregiver
- History of fever for ≤7 days OR hypothermia (i.e., axillary temperature \<35.5ºC) OR suspected severe infection (e.g., in children with moderate or...
- Lives within the catchment area of the study facility and must intend to continue to reside there for the duration of the study
- For the RTI sub-study only: presence of respiratory symptoms compatible with RTI.
You likely can't join if
- Weight less than 2.5kg
- Main reason for consultation is an injury, trauma or acute poisoning
- Enrolled in another clinical trial testing a new drug
- Enrolled in a vaccine trial in the last 3 months.
- Any other condition determined by the investigators that makes it unlikely that the participant would complete the study
The study team makes the final eligibility decision.
Where it's taking place
- Lambaréné, Moyen-Ogooué Province, Gabon
- Mopeia, Mozambique
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 months to 60 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lambaréné, Moyen-Ogooué Province, Gabon; Mopeia, Mozambique. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.